FMP
Tetra Bio-Pharma Inc.
TBP.TO
TSX
Inactive Equity
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.
0.025 CAD
0 (0%)
About
ceo
Dr. Guy Chamberland M.Sc., Master Herbal
sector
Healthcare
industry
Biotechnology
website
https://www.tetrabiopharma.com
exchange
TSX
Description
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.
CIK
N/A
ISIN
CA88166Y1007
CUSIP
N/A
Address
2316 St. Joseph Boulevard
Phone
343 780 2020
Country
CA
Employee
33
IPO Date
Jul 10, 2018
Key Executives
